Regulus Therapeutics Inc. (RGLS)

NASDAQ: RGLS · Real-Time Price · USD

2.550

+0.230 (9.91%)

At close: Apr 23, 2025, 4:00 PM

2.530

-0.020 (-0.78%)

After-hours: Apr 23, 2025, 5:40 PM EDT

Regulus Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Revenue	-	-	-	-	10.01	Upgrade
Revenue Growth (YoY)	-	-	-	-	46.46%	Upgrade
Cost of Revenue	35.37	21.15	18.41	17.79	15.35	Upgrade
Gross Profit	-35.37	-21.15	-18.41	-17.79	-5.34	Upgrade
Selling, General & Admin	14.67	9.96	9.83	10.02	8.81	Upgrade
Operating Expenses	14.67	9.96	9.83	10.02	8.81	Upgrade
Operating Income	-50.04	-31.11	-28.24	-27.82	-14.16	Upgrade
Interest Expense	-0.16	-0.6	-0.69	-0.86	-1.81	Upgrade
Interest & Investment Income	3.84	1.68	0.61	0.2	0.23	Upgrade
EBT Excluding Unusual Items	-46.36	-30.04	-28.32	-28.47	-15.73	Upgrade
Other Unusual Items	-	-	-	0.66	-	Upgrade
Pretax Income	-46.36	-30.04	-28.32	-27.81	-15.73	Upgrade
Income Tax Expense	0	0	0	0	-	Upgrade
Net Income	-46.36	-30.04	-28.32	-27.81	-15.73	Upgrade
Net Income to Common	-46.36	-30.04	-28.32	-27.81	-15.73	Upgrade
Shares Outstanding (Basic)	56	19	15	9	3	Upgrade
Shares Outstanding (Diluted)	56	19	15	9	3	Upgrade
Shares Change (YoY)	197.18%	24.25%	78.07%	145.01%	102.65%	Upgrade
EPS (Basic)	-0.82	-1.58	-1.86	-3.24	-4.50	Upgrade
EPS (Diluted)	-0.82	-1.58	-1.86	-3.24	-4.50	Upgrade
Free Cash Flow	-42.01	-27.38	-25.89	-24.38	-12.54	Upgrade
Free Cash Flow Per Share	-0.75	-1.44	-1.70	-2.85	-3.58	Upgrade
Gross Margin	-	-	-	-	-53.38%	Upgrade
Operating Margin	-	-	-	-	-141.47%	Upgrade
Profit Margin	-	-	-	-	-157.21%	Upgrade
Free Cash Flow Margin	-	-	-	-	-125.28%	Upgrade
EBITDA	-49.69	-30.88	-28.12	-27.36	-13.69	Upgrade
EBITDA Margin	-	-	-	-	-136.80%	Upgrade
D&A For EBITDA	0.35	0.23	0.12	0.46	0.47	Upgrade
EBIT	-50.04	-31.11	-28.24	-27.82	-14.16	Upgrade
EBIT Margin	-	-	-	-	-141.47%	Upgrade
Revenue as Reported	-	-	-	-	10.01	Upgrade

Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q